Memoir Details Author’s Journey with Mental Illness and Disability
Memoir Details Author’s Journey with Mental Illness and Disability Long Island, NY, April 27, 2021 – As we enter Mental Health Awareness month, one author and artist is sharing her coming-of-age story through the lenses of mental illness, disability and steadfast determination. Long Island native Ruth Poniarski’s first book, Journey of the Self: Memoir of an Artist, … Continue reading Memoir Details Author’s Journey with Mental Illness and Disability
Roasted Bean Box Launches World’s First Data-driven Coffee Subscription in Montreal
Roasted Bean Box Launches World’s First Data-driven Coffee Subscription in Montreal Coffee lovers can get the flavors of the world customized to their exact taste preferences and delivered right to their door with Roasted Bean Box’s new subscription service. MONTREAL, April 27, 2021 (GLOBE NEWSWIRE) — Roasted Bean Box, a hot new subscription coffee delivery … Continue reading Roasted Bean Box Launches World’s First Data-driven Coffee Subscription in Montreal
AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer
AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer Health Canada Approval Enables Quick and Accurate Blood Testing TORONTO, April 27, 2021 /CNW/ – AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed … Continue reading AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer
Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel)
Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel) Expansion of treatment centre network includes two specialized centres in Alberta certified to deliver Kymriah to Canadian patients with relapsed/refractory (r/r) pediatric and young adult B-cell ALL and adult r/r DLBCL Alberta joins Quebec and Ontario to reimburse Kymriah therapy for these life-threatening … Continue reading Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel)
Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes
Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes TTI-622 monotherapy shows 33% objective response rate (ORR) in relapsed/refractory (R/R) lymphomas at 0.8-18 mg/kg doses, including 3 new responses (1 Complete Response (CR) + 2 Partial Responses (PRs)) since last data disclosure; TTI-621 monotherapy … Continue reading Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes
